<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352257</url>
  </required_header>
  <id_info>
    <org_study_id>RS/19.21</org_study_id>
    <nct_id>NCT04352257</nct_id>
  </id_info>
  <brief_title>Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia</brief_title>
  <official_title>Bladder and Prostate Sonomorphology as a Useful Tool for Detecting Bladder Outlet Obstruction in Patients With Symptomatic Benign Prostatic Hyperplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic
      Hyperplasia?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bladder and Prostate Sonomorphology as a Useful tool for Detecting Bladder Outlet Obstruction
      in Patients With Symptomatic Benign Prostatic Hyperplasia?
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>pelvic and transrectal ultrasound</measure>
    <time_frame>18 months</time_frame>
    <description>bladder wall thickness, prostate volume, and prostate morphology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pelvic and transrectal ultrasound in relation to pressure flow study</measure>
    <time_frame>18 months</time_frame>
    <description>correlation of the pelvic and transrectal ultrasound parameters to pressure flow study measurements</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>ultrasonography</arm_group_label>
    <description>pelvic and transrectal ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>pelvic Ultrasound</intervention_name>
    <description>pelvic and transrectal ultrasound</description>
    <arm_group_label>ultrasonography</arm_group_label>
    <other_name>transrectal ultrasound</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient more than 50 year old who were presented with Lower urinary tract symptoms.The
        patients were be subjected to pelvic and transrectal ultrasound.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        male patients with LUTS/BPH prostate size &gt; 25 g

        Exclusion Criteria:

        urinary retention diabetes mellitus neurologic deficit LUTS medications prior lower urinary
        tract surgery concomitant bladder pathology small bladder capacity (&lt; 150 ml) urethral
        stricture evident prostate carcinoma.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diaa Eldin Taha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of urology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diaa Eldin Taha, MD</last_name>
    <phone>01008531384</phone>
    <email>drdiaaeldin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kafrelsheikh faculty of medicine</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <state>Kafrelsheikh</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diaa ELDIN Taha, MD</last_name>
      <phone>01008531384</phone>
      <email>drdiaaeldin@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 12, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Diaa Eldin Taha Ramadan Mohamed</investigator_full_name>
    <investigator_title>Lecturer of urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

